Aquaculture biotech group Benchmark secures capital for new sealice treatment

The offer opened on Jan. 30.

Benchmark Holding: Kevin Quinn, Hugo Wahnesh, Malcolm Pye, Peter George and Yngve Myhre. — Benchmark Holding: Kevin Quinn, Hugo Wahnesh, Malcolm Pye, Peter George and Yngve Myhre.Photo: Bent-Are Jensen

Demi Korban

Published 17 February 2020, 09:01Updated 17 February 2020, 09:01

Benchmark biotech Sea lice